Author:
Kumar Rakesh,Gupta Ravi Kant,Agarwal Krishan Kant,Yusuf Siraj
Publisher
Springer International Publishing
Reference36 articles.
1. Avril N, Dose J, Janicke F, et al. Metabolic characterization of breast tumours with positron emission tomography using 18F-fluorodeoxyglucose. J Clin Oncol. 1996;14:1848–57.
2. Avril N, Scheidhauer K, Kuhun W. Breast cancer. In: Helmut J, Wieler R, Coleman E, editors. PET in clinical oncology. New York: Springer; 2000. p. 355–72.
3. Barranger E, Grahek D, Antoine M, et al. Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer. Ann Surg Oncol. 2003;10:622–7.
4. Cook G, Houston S, Rubens R, et al. Detection of bone metastases in breast cancer by 18F-FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol. 1998;16:3375–9.
5. Dose Schwarz J, Bader M, Jenicke L, et al. Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET. J Nucl Med. 2005;46:1144–50.